Author:
Singh Rajan,Anand Anshul,Rawat Arun K.,Saini Shashi,Mahapatra Baishakhi,Singh Naveen K.,Mishra Alok K.,Singh Samer,Singh Nisha,Kishore Dhiraj,Kumar Vinod,Das Pradeep,Singh Rakesh K.
Abstract
The parasites of the genusLeishmaniasurvive and proliferate in the host phagocytic cells by taking control over their microbicidal functions. The parasite also promotes differentiation of antigen-specific anti-inflammatory cytokines producing effector T cells, which eventually results in disease pathogenesis. The mechanisms that parasites employ to dominate host adaptive immunity are largely unknown. For the first time, we report thatL. donovani, which causes visceral leishmaniasis in the Indian subcontinent, upregulates the expression of an immune inhibitory receptor i.e., CD300a on antigen presenting and phagocytic cells to dampen their effector functions. The blocking of CD300a signals in leishmania antigens activated macrophages and dendritic cells enhanced the production of nitric oxide, pro-inflammatory cytokines along with MHCI/II genes expression, and reduced parasitic uptake. Further, the abrogation of CD300a signals inLeishmaniainfected mice benefited antigen-experienced, i.e., CD4+CD44+and CD8+CD44+T cells to acquire more pro-inflammatory cytokines producing phenotypes and helped in the early clearance of parasites from their visceral organs. The CD300a receptor blocking also enhanced the conversion of CD4+T effectors cells to their memory phenotypes i.e., CCR7highCD62Lhighup to 1.6 and 1.9 fold after 14 and 21 days post-infection, respectively. These findings implicate that CD300a is an important determinant of host phagocytic cells functions and T cells differentiation againstLeishmaniaantigens.
Funder
Department of Biotechnology, Ministry of Science and Technology, India
Subject
Immunology,Immunology and Allergy
Reference68 articles.
1. Leishmaniasis Revisited: Current Aspects on Epidemiology, Diagnosis, and Treatment;Georgiadou;J Transl Int Med,2015
2. Drug Resistance and Treatment Failure in Leishmaniasis: A 21st-Century Challenge;Ponte-Sucre;PLoS Negl Trop Dis,2017
3. Increasing Failure of Miltefosine in the Treatment of Kala-Azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance;Rijal;Clin Infect Dis,2013
4. Unusual Case of Resistance to Amphotericin B in Visceral Leishmaniasis in a Region in India Where Leishmaniasis Is Not Endemic;Srivastava;J Clin Microbiol,2011
5. Post Kala-Azar Dermal Leishmaniasis Following Treatment With 20 Mg/Kg Liposomal Amphotericin B (Ambisome) for Primary Visceral Leishmaniasis in Bihar, India;Burza;PLoS Negl Trop Dis,2014
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献